- Exchange: EN Brussels
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
TiGenix NV+ Add to Watchlist
TIG:BB0.7570 EUR 0.0010 0.13%
As of 04:13:41 ET on 03/06/2015.
Company Profile for TiGenix NV (TIG)
TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.
Key Executives for TiGenix NV (TIG)
|Eduardo Bravo Fernandez De AraozCEO/Managing Director||Claudia D AugustaCFO/Secy/Compliance Officer|
|Wilfried DalemansChief Technology Officer||Marie Paule RichardChief Medical Officer|
|Hans HerklotsDir:Investor & Media Relations|